ArticleCureus2025
Mortality From Parkinson's Disease With Influenza and Pneumonia as Contributing Causes in the United States, 1999-2020.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundParkinson's disease (PD) is a progressive neurodegenerative disorder and a leading cause of morbidity and mortality among older adults. Respiratory infections such as influenza and pneumonia further increase mortality due to impaired cough reflex, dysphagia, and reduced immunity. Limited research has examined long-term mortality trends where these infections contribute to PD-related deaths. AIMS AND
objectivesThis study aimed to evaluate the crude and age-adjusted mortality rates (AAMRs) of individuals with PD where influenza or pneumonia were contributing factors.
methodsWe conducted a retrospective study using the CDC Wide-Ranging Online Data for Epidemiologic Research (WONDER) Multiple Cause of Death (MCD) database (1999-2020). Individuals aged ≥45 years with PD (ICD-10: G20) as the underlying cause of death and influenza or pneumonia (ICD-10: J09-J18) as contributing causes were included. Mortality rates were calculated per 1,000,000 population and age-adjusted to the 2000 US Standard Population. Demographic, geographic, and temporal patterns were analyzed using JoinPoint regression.
resultsFrom 1999 to 2020, 43,644 deaths were identified. Males accounted for 28,831 deaths (66.1%), and White individuals accounted for 40,716 deaths (93.3%). Most deaths occurred in metropolitan areas (35,261 deaths, 80.8%) and nursing homes/long-term care facilities (19,223 deaths, 44%). The crude mortality rate was 16.6 per 1,000,000 population. AAMRs showed a significant overall decline (annual percentage change (APC), -4.41%; p < 0.05). Male mortality remained consistently higher than female mortality (14,813 deaths, 33.9%). Racial disparities were observed, with White individuals showing the greatest burden (40,716 deaths, 93.3%), while Black (1,581 deaths, 3.6%) and Asian or Pacific Islander groups (1,205 deaths, 2.8%) demonstrated fluctuating but declining trends.
conclusionMortality from PD with influenza or pneumonia declined significantly between 1999 and 2020, reflecting improvements in infection control and elderly care. However, disparities by sex, race, and geography persist, underscoring the need for targeted interventions, particularly in long-term care settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.